Navigation Links
Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
Date:10/19/2009

ASTIN and PROLASTIN-C are made from human plasma. Products made from human plasma may contain infectious agents, such as viruses and, theoretically, the Creutzfeldt-Jakob (CJD) agent that can cause disease, and cannot be totally eliminated. There is also the possibility that unknown infectious agents may be present in such products. Individuals with selective IgA deficiencies who have the known antibody against IgA (anti-IgA antibody) should not receive PROLASTIN or PROLASTIN-C, since these patients may experience severe reactions, including anaphylaxis, to IgA which may be present. For additional information on PROLASTIN, please see full prescribing information at www.PROLASTIN.com.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

About Alpha1-Antitrypsin Deficiency

Alpha1-antitrypsin deficiency, also known as AAT deficiency or Alpha-1, is an inherited disorder that causes significant reduction in the naturally occurring protein AAT. It is most common in the Caucasian population of northern Europe and North America. AAT deficiency is also the most common cause of genetic liver disease in children, and genetic emphysema (shortness of breath) in adults. Individuals suffering from AAT deficiency often develop severe obstructive pulmonary disease (COPD) causing disability and premature death. AAT deficiency is estimated to affect 200,000 people in North America and Europe.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology an
'/>"/>

SOURCE Talecris Biotherapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
2. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
3. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
4. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
5. Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
6. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
7. Oxygen Biotherapeutics, Inc. Submits Milestone Achievement Notice to Vatea Fund
8. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
9. Oxygen Biotherapeutics, Inc. to Webcast Shareholder Meeting
10. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
11. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013  Medicare Part D ... overwhelmingly satisfied, citing lower costs, convenient access to ... survey from Hart Research Associates released today by ... 40% of Part D seniors (9.5 million) are ... "Seniors like the lower costs, pharmacy choices, ...
(Date:5/19/2013)... , May 20, 2013 Claret Medical, Inc. ... Nicolas Van Mieghem et al., Histopathology ... Published ahead of print in Circulation, May 7 th ... Medical Center, Rotterdam, the Netherlands and ... of the Cardiovascular Pathology Institute, Gaithersburg, Maryland.  ...
(Date:5/18/2013)... May 18, 2013 The Open Paradigm ... Occupy Psychiatry , and leading organizations ... announces a social media campaign showcasing video testimonials ... model, which focuses on pathology and illness rather ... the American Psychiatric Association,s (APA) rollout of its ...
Breaking Medicine Technology:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3
... N.J., Oct. 12 Schering-Plough Corporation (NYSE: SGP ) ... the 2009 third quarter on Thursday, Oct. 22, 2009. ... Schering-Plough will conduct a conference call to review results for ... CEO, and other members of management will host the conference ...
... , ANN ARBOR, Mich., Oct. 12 The University ... (®) from Thomson Reuters to provide physicians, nurses, and ... electronic drug dosing, interaction checking, and reference information. ... 575-bed academic medical center that specializes in heart disease, ...
Cached Medicine Technology:Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings 2University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 2University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 3
(Date:5/20/2013)... 2013 According to a June 2009 ... medical malpractice amount to approximately $3.6 billion dollars per ... Healthcare Improvement estimated that there 15 million incidents of ... suggest that everyone who receives any form of medical ... malpractice. Merriam-Webster defines malpractice as “a dereliction of ...
(Date:5/20/2013)... The judge overseeing pretrial proceedings in the federal ... female lawyers to be included in a plaintiffs’ leadership ... acknowledges the judge’s request, noting that its lawyers ... on Mirena side effects and how to file a ... of some female lawyers to the committee. This followed ...
(Date:5/20/2013)... Arlington, VA (PRWEB) May 20, 2013 ... Service Project , Who:    Sloan Gibson, President, ... Chwatsky, Vice President of Outreach Initiatives ... Monster, Sesame Street , Representatives from:, ... Senate ,          • ...
(Date:5/20/2013)... 2013 The American Society for Clinical ... Pink®, the organization that empowers young women to be proactive ... 2012. Thanks to its members, ASCP raised more than $6,000 ... in Relay for Life at the local level. When he ... to donate. “I was made aware of the opportunity when ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 For more ... have waged a battle against drug and alcohol abuse ... has released its first guide to help Italian speakers ... published by the European Monitoring Centre for Drugs and ... four have used cannabis in the last year. As ...
Breaking Medicine News(10 mins):Health News:Law Firm Releases New Informational Graphic on the Basics of Understanding Medical Malpractice Cases 2Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 3Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 4Health News:ASCP Members Rally Around Breast and Ovarian Cancer Awareness 2Health News:ASCP Members Rally Around Breast and Ovarian Cancer Awareness 3Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2
... new study from Utrecht and Cambridge Universities has for ... under the tongue in volunteers negatively affects a person,s ... The findings are published this week in the journal ... In addition, the effects of testosterone administration are predicted ...
... Spanish . Researchers from the Hospital Virgen de ... identified the most frequent mutations in the gene KCNH2 in ... a disorder of cardiac ionic channels that approximately affects one ... episodes, which can trigger sudden death. This condition usually affects ...
... cancer in Europe in 2011 according to predictions from a ... today (Wednesday 9 February) [1]. The estimates, ... time in Europe a new mathematical model for predicting cancer ... both men and women when compared to 2007. But they ...
... a time when the effects of paediatric oncology research have ... is too low and dependent on short-term grants to be ... report supported by the EU-funded 7th Framework Programme project Eurocancercoms ... authors also looked at the citation impact of paediatric oncology ...
... CHICAGO Among patients with early-stage breast cancer that had ... that included lumpectomy and radiation therapy, women who just had ... which cancer is likely to spread from the primary tumor) ... extensive axillary lymph node dissection (surgery to remove lymph nodes ...
... common cause of death among patients with pneumonia, sepsis or ... damage often occurs suddenly and can cause life-threatening breathing problems ... Patients usually are put on ventilators to give their lungs ... can do but wait and hope for the best. ...
Cached Medicine News:Health News:Extra testosterone reduces your empathy 2Health News:Researchers identify the genotype of disorders causing cardiac sudden death syndrome 2Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 2Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 3Health News:Childhood cancer research in danger 2Health News:Childhood cancer research in danger 3Health News:Limited lymph node removal for certain breast cancer does not appear to result in poorer survival 2Health News:Gene protects lung from damage due to pneumonia, sepsis, trauma, transplants 2Health News:Gene protects lung from damage due to pneumonia, sepsis, trauma, transplants 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: